CIK 0000926617
- Non-accelerated filer
- Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330595156
- Phone
- +1 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- 4 Open-market buy VP Sales and Marketing bought 374 shares at $5.28 ($1,975)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 18,200 shares (grant or award)
- 4 Grant or award Director acquired 19,200 shares (grant or award)
- 4 Grant or award Director acquired 15,200 shares (grant or award)
- 4 Grant or award Director acquired 15,200 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award VP & Chief Financial Officer acquired 24,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 85,000 shares (grant or award)
- 4 Grant or award SVP and Chief Science Officer acquired 41,000 shares (grant or award)
- 4 Grant or award VP Sales and Marketing acquired 20,000 shares (grant or award)
- 4 Grant or award VP of Corporate Strategy acquired 7,000 shares (grant or award)
- 4 Open-market sale Chief Executive Officer sold 45,000 shares at $5.92 ($266,400)
- 4 Open-market sale Director sold 6,000 shares at an average $5.68 ($34,075)
- 4 Grant or award Chief Executive Officer acquired 181,525 shares (grant or award)
- 4 Grant or award Director acquired 13,000 shares (grant or award)
- 4 Grant or award Director acquired 17,500 shares (grant or award)
- 4 Grant or award Director acquired 13,000 shares (grant or award)
- 4 Grant or award Director acquired 22,000 shares (grant or award)
- 4 Grant or award Director acquired 15,500 shares (grant or award)
Page 21 of 28 · 551 filings